PF4 and COVID-19: Platelet activation is a major driver of inflammation/thrombogenesis, and von Willebrand factor (vWF) and Platelet Factor 4 (PF4) are deeply involved in the pathogenesis of COVID-19-associated coagulopathy [123,124].